FTC Puts Conditions on Valeant Pharmaceuticals’ Proposed Acquisition of Precision Dermatology
Date
Valeant Pharmaceuticals International, Inc. and Precision Dermatology, Inc. have agreed to sell or relinquish rights to Precision’s branded single-agent topical tretinoins and generic Retin-A, common...